Fujifilm Irvine Scientific Inc. caused a significant emotional and economic toll on likely hundreds of fertility patients when it distributed defective mineral oil that’s used to culture embryos during in vitro fertilization treatment, a proposed class action alleges.
The medical lab allegedly breached its duty to ensure that its products met the required specifications by failing to inspect more than 15,000 bottles of the oil. By the time the company issued a recall, likely hundreds of embryos were already “impaired, damaged, and lost,” a complaint filed Tuesday in the US District Court for the Central District of California claims.
The ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.